These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9551171)

  • 61. ANTIMICROBIAL PROPERTIES OF NATIVE ULSTER MACROFUNGI (MUSHROOMS AND TOADSTOOLS) TO CLINICAL PATHOGENS.
    Nelson D; Moore JE; Millar BC; Rao JR
    Ulster Med J; 2019 May; 88(2):130-132. PubMed ID: 31105354
    [No Abstract]   [Full Text] [Related]  

  • 62. Intraphagocytic bioactivity of lomefloxacin against Pseudomonas aeruginosa.
    Cantón E; Jiménez T; Pemán J; Ramón MS; Gobernado M
    J Antimicrob Chemother; 1993 Aug; 32(2):279-84. PubMed ID: 8226429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.
    Vera-Cabrera L; Ochoa-Felix EY; Gonzalez G; Tijerina R; Choi SH; Welsh O
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1037-9. PubMed ID: 14982804
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The synthesis of fluorine-18 lomefloxacin and its preliminary use in human studies.
    Tewson TJ; Yang D; Wong G; Macy D; DeJesus OJ; Nickles RJ; Perlman SB; Taylor M; Frank P
    Nucl Med Biol; 1996 Aug; 23(6):767-72. PubMed ID: 8940719
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concentration of enrofloxacin in equine tissues after long-term oral administration.
    Giguère S; Bélanger M
    J Vet Pharmacol Ther; 1997 Oct; 20(5):402-4. PubMed ID: 9350262
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effect of lomefloxacin on luminol-dependent chemiluminescence and adhesion of leukocytes].
    Iordanova AI; Nikitin AV
    Antibiot Khimioter; 1996 Jan; 41(1):3-6. PubMed ID: 8762817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Entry of lomefloxacin and temafloxacin into human neutrophils, peritoneal macrophages, and tissue culture cells.
    Pascual A; Garcia I; Perea EJ
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):393-8. PubMed ID: 1322808
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2001; 46(8):3-5. PubMed ID: 11871317
    [No Abstract]   [Full Text] [Related]  

  • 69. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].
    Padeĭskaia EN
    Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937
    [No Abstract]   [Full Text] [Related]  

  • 70. Disk susceptibility testing for rufloxacin.
    Andrews JM; Wise R
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):974-6. PubMed ID: 8187800
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of food on absorption of lomefloxacin.
    Hooper WD; Dickinson RG; Eadie MJ
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1797-9. PubMed ID: 2285293
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Lomefloxacin pharmacokinetics in patients in the terminal stage of chronic renal insufficiency, undergoing treatment with programmed hemodialysis].
    Kolendo SE; Vorob'ev PA; Dvoretskiĭ LI; Izotova GN; Miagkov AV; Shvyreva GS; Iakovlev SV
    Antibiot Khimioter; 1995 Mar; 40(3):47-51. PubMed ID: 7575015
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of fluoroquinolones on the gastrointestinal flora.
    Murray BE
    Rev Infect Dis; 1989; 11 Suppl 5():S1372-8. PubMed ID: 2672259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of lomefloxacin on phagocytosis and killing activity of macrophages and neutrophils.
    Mato R; Corrales I; Prieto J
    J Antimicrob Chemother; 1992 Oct; 30(4):558-9. PubMed ID: 1337071
    [No Abstract]   [Full Text] [Related]  

  • 75. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.
    Poole K
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2595-9. PubMed ID: 10991829
    [No Abstract]   [Full Text] [Related]  

  • 76. Penetration of lomefloxacin into human prostatic tissue.
    Leroy A; Grise P; Dhib M; Valtchev B; Fillastre JP
    Urology; 1991 Aug; 38(2):192. PubMed ID: 1877143
    [No Abstract]   [Full Text] [Related]  

  • 77. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.
    Poole K
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2233-41. PubMed ID: 10952561
    [No Abstract]   [Full Text] [Related]  

  • 78. The quinolones. An overview of their pharmacology.
    Fitton A
    Clin Pharmacokinet; 1992; 22 Suppl 1():1-11. PubMed ID: 1319865
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New quinolones and gram-positive bacteria.
    Piddock LJ
    Antimicrob Agents Chemother; 1994 Feb; 38(2):163-9. PubMed ID: 8192436
    [No Abstract]   [Full Text] [Related]  

  • 80. Disposable antimicrobial and sporicidal privacy curtains: Cost benefit of hanging longer.
    Kotsanas D; Gillespie E
    Am J Infect Control; 2016 Jul; 44(7):854-5. PubMed ID: 26922893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.